Quality of Life with Localized Prostate Cancer: Japanese Perspectives

  • S. Namiki
  • L. Kwan
  • Y. Arai
Reference work entry


With the established effectiveness of diverse treatments for localized prostate cancer, identification of the physical and psychological consequences of the disease and various treatments becomes critical. Race and ethnicity are important factors in health-related quality of life (HRQOL) because preferences and health system trust factors that are predominant in certain racial groups are likely to influence HRQOL and satisfaction with care. In Japan, increased screening for prostate cancer has lead to an increase in the apparent incidence of prostate cancer, and resulted in a shift to an earlier age and stage at diagnosis, a trend similar to that in US or European countries. The aim of this article is to selectively review the current research findings related to HRQOL for Japanese men with localized prostate cancer. Studies show that prostate cancer treatment affects both disease-specific HRQOL (i.e., urinary, sexual and bowel function and bother) as well as general HRQOL (i.e., energy/vitality, performance inn physical and social roles). In addition, race/ethnicity (Japanese vs. American men) independently predicted the patterns of urinary and sexual recovery up to 24 months after curative therapy for localized prostate cancer. More attention should be given to fully evaluating HRQOL in Asian populations including Japanese men with localized prostate cancer.


Prostate Cancer Radical Prostatectomy Sexual Function Lower Urinary Tract Symptom Androgen Deprivation Therapy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

List of Abbreviations:


androgen deprivation therapy


external beam radiation therapy


health-related quality of life


prostate specific antigen


radical prostatectomy


watchful waiting


  1. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC. (1993). J Natl Cancer Inst. 85: 365–376.PubMedCrossRefGoogle Scholar
  2. Akaza H, Hinotsu S, Usami M, Ogawa O, Kagawa S, Kitamura T, Tsukamoto T, Naito S, Hirao Y, Murai M, Yamanaka H, Namiki M. (2006). J Urol. 176: S47–49.PubMedCrossRefGoogle Scholar
  3. Akakura K, Isaka S, Akimoto S, Ito H, Okada K, Hachiya T, Yoshida O, Arai Y, Usami M, Kotake T, Tobisu K, Ohashi Y, Sumiyoshi Y, Kakizoe T, Shimazaki J. (1999). Urology. 54: 313–318.PubMedCrossRefGoogle Scholar
  4. Andersson SO, Rashidkhani B, Karlberg L, Wolk A, Johansson JE. (2004). BJU Int. 94: 323–331.Google Scholar
  5. Arai Y, Okubo K, Aoki Y, Maekawa S, Okada T, Maeda H, Ogawa O, Kato T. (1999) Int J Urol. 6: 78–86.PubMedCrossRefGoogle Scholar
  6. Bill-Axelson A, Holmberg L, Ruutu M, Häggman M, Andersson SO, Bratell S, Spångberg A, Busch C, Nordling S, Garmo H, Palmgren J, Adami HO, Norlén BJ, Johansson JE, Scandinavian Prostate Cancer Group Study No. 4. (2005). N Engl J Med. 352: 1977–1984.PubMedCrossRefGoogle Scholar
  7. Blanker MH, Bohnen AM, Groeneveld FP, Bernsen RM, Prins A, Ruud Bosch JL. (2000). J Urol. 164: 1201–1205.PubMedCrossRefGoogle Scholar
  8. Cancer Registration Committee of the Japanese Urological Association. (2005). Int J Urol. 12: 46–49.CrossRefGoogle Scholar
  9. Carlson KV, Nitti VW. (2001). Urol Clin North Am. 28: 595–612.PubMedCrossRefGoogle Scholar
  10. Catalona WJ, Carvalhal GF, Mager DE, Smith DS. (1999). J Urol. 162: 433–438.PubMedCrossRefGoogle Scholar
  11. Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, Silberman M, Yellen SB, Winicour P, Brannon J. (1993). J Clin Oncol. 11: 570–579.PubMedGoogle Scholar
  12. Cooperberg MR, Broering JM, Litwin MS, Lubeck DP, Mehta SS, Henning JM, Carroll PR. (2004). CaPSURE Investigators J Urol. 171: 1393–1401.PubMedCrossRefGoogle Scholar
  13. Cooperberg MR, Master VA, Carroll PR. (2003). J Urol. 170: 512–515.PubMedCrossRefGoogle Scholar
  14. Downs TM, Sadetsky N, Pasta DJ, Grossfeld GD, Kane CJ, Mehta SS, Carroll PR, Lubeck DP. (2003). J Urol. 170: 1822–1827.PubMedCrossRefGoogle Scholar
  15. Egawa S, Shimura S, Irie A, Kitano M, Nishiguchi I, Kuwao S, Hayakawa K, Baba S. (2003). Int J Urol. 10: 207–212.PubMedCrossRefGoogle Scholar
  16. Esper P, Mo F, Chodak G, Sinner M, Cella D, Pienta KJ. (1997). Urology. 50: 920–928.PubMedCrossRefGoogle Scholar
  17. Eton DT, Lepore SJ, Helgeson VS. (2001). Cancer. 92: 1451–1459.PubMedCrossRefGoogle Scholar
  18. Frank SJ, Pisters LL, Davis J, Lee AK, Bassett R, Kuban DA. (2007). J Urol. 177: 2151–2156.PubMedCrossRefGoogle Scholar
  19. Fowler FJ Jr., Barry MJ, Lu-Yao G, Wasson JH, Bin L. (1996). J Clin Oncol. 14: 2258–2265.PubMedGoogle Scholar
  20. Gill TM, Feinstein AR. (1994). JAMA. 272: 619–626.PubMedCrossRefGoogle Scholar
  21. Gontero P, Fontana F, Bagnasacco A, Panella M, Kocjancic E, Pretti G, Frea B. (2003). J Urol. 169: 2166–2169.PubMedCrossRefGoogle Scholar
  22. Hara I, Kawabata G, Miyake H, Nakamura I, Hara S, Okada H, Kamidono S. (2003). J Urol. 169: 2045–2048.PubMedCrossRefGoogle Scholar
  23. Hashine K, Azuma K, Koizumi T, Sumiyoshi Y. (2005). Int J Clin Oncol. 10: 45–50.PubMedCrossRefGoogle Scholar
  24. Heer HW, O’sullivan M. (2000). J Urol. 163: 1743–1746.CrossRefGoogle Scholar
  25. Hisasue S, Kumamoto Y, Sato Y, Masumori N, Horita H, Kato R, Kobayashi K, Hashimoto K, Yamashita N, Itoh N. (2005). Urology. 65: 143–148.PubMedCrossRefGoogle Scholar
  26. Hoffman RH, Hunt WC, Stephenson RA. (2003). Cancer. 97: 1653–1662.PubMedCrossRefGoogle Scholar
  27. Ishihara M, Suzuki H, Akakura K, Komiya A, Imamoto T, Tobe T, Ichikawa T. (2006). Int J Urol. 13: 920–92.PubMedCrossRefGoogle Scholar
  28. Jayadevappa R, Johnson JC, Chhatre S, Wein AJ, Malkowicz SB. (2007). Cancer. 109: 2229–2238.PubMedCrossRefGoogle Scholar
  29. Johnson TK, Gilliland FD, Hoffman RM, Deapen D, Penson DF, Stanford JL, Albertsen PC, Hamilton AS. (2004). J Clin Oncol. 22: 4193–4201.PubMedCrossRefGoogle Scholar
  30. Kakehi Y, Kamoto T, Ogawa O, Arai Y, Litwin MS, Suzukamo Y, Fukuhara S. (2002). Int J Clin Oncol. 7: 306–311.PubMedGoogle Scholar
  31. Kakehi Y, Takegami M, Suzukamo Y, Namiki S, Arai Y, Kamoto T, Ogawa O, Fukuhara S. (2007). J Urol. 177: 1856–1861.PubMedCrossRefGoogle Scholar
  32. Kato T, Komiya A, Suzuki H, Imamoto T, Ueda T, Ichikawa T. (2007). Int J Urol. 14: 416–421.PubMedCrossRefGoogle Scholar
  33. Krupski TL, Saigal CS, Litwin MS. (2003). J Urol. 170: 1291–1294.PubMedCrossRefGoogle Scholar
  34. Litwin MS, Flanders SC, Pasta DJ, Stoddard ML, Lubeck DP, Henning JM. (1999). Urology. 54: 503–508.PubMedCrossRefGoogle Scholar
  35. Litwin MS, Hays RD, Fink A, Ganz PA, Leake B, Brook RH. (1998a). Med Care. 36: 1002–1012.PubMedCrossRefGoogle Scholar
  36. Litwin MS, Hays RD, Fink A, Ganz PA, Leak B, Leach GE, Brook RH. (1995). JAMA. 273: 129–135.PubMedCrossRefGoogle Scholar
  37. Litwin MS, Lubeck DP, Henning JM, Carroll PR. (1998b). J Urol. 159: 988–992.CrossRefGoogle Scholar
  38. Litwin MS, Lubeck DP, Spitalny GM, Henning JM, Carroll PR. (2002). Cancer. 95: 54–60.PubMedCrossRefGoogle Scholar
  39. Lubeck DP, Kim H, Grossfeld G, Ray P, Penson DF, Flanders SC, Carroll PR. (2001). J Urol. 166: 2281–2285.PubMedCrossRefGoogle Scholar
  40. Lubeck DP, Litwin MS, Henning JM, Stoddard ML, Flanders SC and Carroll PR. (1999). Urology. 53: 180–186.PubMedCrossRefGoogle Scholar
  41. Marumo K, Nakashima J, Murai M. (2001). Int J Urol. 8: 53–59.PubMedCrossRefGoogle Scholar
  42. Masumori N, Tsukamoto T, Kumamoto Y, Panser LA, Rhodes T, Girman CJ, Lieber MM, Jacobsen SJ. (1999). Urology. 54: 335–344.PubMedCrossRefGoogle Scholar
  43. Matsubara A, Yasumoto H, Mutaguchi K, Mita K, Teishima J, Seki M, Kajiwara M, Kato M, Shigeta M, Usui T. (2005). Int J Urol. 12: 953–958.PubMedCrossRefGoogle Scholar
  44. Merrick GS, Butler WM, Galbreath RW, Stipetich RL, Abel LJ, Lief JH. (2002). Int J Radiat Oncol Biol Phys. 52: 893–902.PubMedCrossRefGoogle Scholar
  45. Mizokami A, Ueno S, Fukagai T, Ito K, Ehara H, Kinbara H, Origasa H, Usami M, Namiki M, Akaza H. (2007) BJU Int. 99 Suppl 1: 6–9.PubMedCrossRefGoogle Scholar
  46. Nakata S, Ohtake N, Kubota Y, Imai K, Yamanaka H, Ito Y, Hirayama N, Hasegawa K. (1998). Int J Urol. 5: 364–369.PubMedCrossRefGoogle Scholar
  47. Namiki S, Egawa S, Baba S, Terachi T, Usui Y, Terai A, Tochigi T, Kuwahara M, Ioritani N, Arai Y. (2005a). Urology. 65: 517–523.PubMedCrossRefGoogle Scholar
  48. Namiki S, Ishidoya S, Saito S, Satoh M, Tochigi T, Ioritani N, Yoshimura K, Terai A, Arai Y. (2006a). Urology. 68: 142–147.PubMedCrossRefGoogle Scholar
  49. Namiki S, Ishidoya S, Tochigi T, Kawamura S, Kuwahara M, Terai A, Yoshimura K, Numata I, Satoh M, Saito S, Takai Y, Yamada S, Arai Y. (2006b). Jpn J Clin Oncol. 36: 224–230.PubMedCrossRefGoogle Scholar
  50. Namiki S, Kwan L, Kagawa-Singer M, Arai Y, Litwin MS. (2008b). Urology. 71: 901–905.PubMedCrossRefGoogle Scholar
  51. Namiki S, Kwan L, Kagawa-Singer M, Saito S, Terai A, Satoh T, Baba S, Arai Y, Litwin MS. (2008c). J Urol. 179: 245–249.PubMedCrossRefGoogle Scholar
  52. Namiki S, Kwan L, Kagawa-Singer M, Tochigi T, Ioritani N, Terai A, Arai Y, Litwin MS. (2008a). Prostate Cancer Prostatic Dis. 11: 298–302.PubMedCrossRefGoogle Scholar
  53. Namiki S, Saito S, Nakagawa H, Sanada T, Yamada A, Arai Y. (2007b). J Urol. 178: 212–216.PubMedCrossRefGoogle Scholar
  54. Namiki S, Saito S, Satoh M, Ishidoya S, Kawamura S, Tochigi T, Kuwahara M, Aizawa M, Ioritani N, Yoshimura K, Ichioka K, Terai A, Arai Y. (2005b). Jpn J Clin Oncol. 35: 551–558.PubMedCrossRefGoogle Scholar
  55. Namiki S, Saito S, Tochigi T, Kuwahara M, Ioritani N, Yoshimura K, Terai A, Koinuma N, Arai Y. (2005c). Int J Urol. 12: 173–181.PubMedCrossRefGoogle Scholar
  56. Namiki S, Saito S, Tochigi T, Numata I, Ioritani N, Arai Y. (2007c). Int J Urol. 14: 924–929.PubMedCrossRefGoogle Scholar
  57. Namiki S, Satoh T, Baba S, Ishiyama H, Hayakawa K, Saito S, Arai Y. (2006c). Urology. 68: 1230–1236.PubMedCrossRefGoogle Scholar
  58. Namiki S, Takegami M, Kakehi Y, Suzukamo Y, Fukuhara S, Arai Y. (2007d). J Urol. 178: 473–477.PubMedCrossRefGoogle Scholar
  59. Namiki S, Tochigi T, Kuwahara M, Ioritani N, Terai A, Numata I, Satoh M, Saito S, Koinuma N, Arai Y. (2004a). Int J Urol. 11: 619–627.PubMedCrossRefGoogle Scholar
  60. Namiki S, Tochigi T, Kuwahara M, Ioritani N, Yoshimura K, Terai A, Nakagawa H, Ishidoya S, Satoh M, Ito A, Saito S, Koinuma N, Arai Y. (2004b). Int J Urol. 11: 742–749.PubMedCrossRefGoogle Scholar
  61. Okaneya T, Nishizawa S, Nakayama T, Kamigaito T, Hashida I, Hosaka N. (2007). Int J Urol. 14: 602–606.PubMedCrossRefGoogle Scholar
  62. Parkin DM, Bray FI, Devesa SS. (2001). Eur J Cancer. 37(Suppl. 8): S4–66.PubMedCrossRefGoogle Scholar
  63. Patrick DL, Deyo RA. (1989). Med Care. 27: S217–232.PubMedCrossRefGoogle Scholar
  64. Potosky AL, Davis WW, Hoffman RM, Stanford JL, Stephenson RA, Penson DF, Harlan LC. (2004). J Natl Cancer Inst. 96: 1358–1367.PubMedCrossRefGoogle Scholar
  65. Potosky AL, Reeve BB, Clegg LX, Hoffman RM, Stephenson RA, Albertsen PC, Gilliland FD, Stanford JL. (2002). J Natl Cancer Inst. 94: 430–437.PubMedGoogle Scholar
  66. Potters L, Klein EA, Kattan MW, Reddy CA, Ciezki JP, Reuther AM, Kupelian PA. (2004). Radiother Oncol. 71: 29–33.PubMedCrossRefGoogle Scholar
  67. Ramsey SD, Zeliadt SB, Hall IJ, Ekwueme DU, Penson DF. (2007). J Urol. 177: 1992–1999.PubMedCrossRefGoogle Scholar
  68. Rose A, Peters N, Shea JA, Armstrong K. (2004). J Gen Intern Med. 19: 57–63.PubMedCrossRefGoogle Scholar
  69. Scardino PT, Kim ED. (2001). Urology. 57: 1016–1019.PubMedCrossRefGoogle Scholar
  70. Schwartz EJ, Lepor H. (1999). J Urol. 161: 1185–1188.PubMedCrossRefGoogle Scholar
  71. Shabsigh R, Perelman MA, Laumann EO, Lockhart DC. (2004). BJU Int. 94: 1055–1065.PubMedCrossRefGoogle Scholar
  72. Shaw PA, Etzioni R, Zeliadt SB, Mariotto A, Karnofski K, Penson DF, Weiss NS, Feuer EJ. (2004). Am J Epidemiol. 160: 1059–1069.PubMedCrossRefGoogle Scholar
  73. Takahashi M, Kai I, Hisata M, Higashi Y. (2006). J Clin Oncol. 24: 5763–5768.PubMedCrossRefGoogle Scholar
  74. Talcott JA, Rieker P, Clark JA, Propert KJ, Weeks JC, Beard CJ, Wishnow KI, Kaplan I, Loughlin KR, Richie JP, Kantoff PW. (1998). J Clin Oncol. 16: 275–283.PubMedGoogle Scholar
  75. Tubaro A, La Vecchia C. (2004). Eur Urol. 45: 767–772.PubMedCrossRefGoogle Scholar
  76. Visser A, van Andel G, Willems P, Voogt E, Dijkstra A, Rovers P, Goodkin K, Kurth KH. (2003). Patient Educ Couns. 49: 225–232.PubMedCrossRefGoogle Scholar
  77. Ware JE and Sherbourne CD. (1992). Med Care. 30: 473–483.PubMedCrossRefGoogle Scholar
  78. Wei JT, Dunn RL, Litwin MS, Sandler HM, Sanda MG. (2000). Urology. 56: 899–905.PubMedCrossRefGoogle Scholar
  79. Yoshimura K, Arai Y, Ichioka K, Matsui Y, Ogura K, Terai A. (2004). Prostate Cancer Prostatic Dis. 7: 144–151.PubMedCrossRefGoogle Scholar
  80. Yoshimura K, Kamoto T, Nakamura E, Segawa T, Kamba T, Takahashi T, Nishiyama H, Ito N, Takayama K, Mizowaki T, Mitsumori M, Hiraoka M, Ogawa O. (2007). Prostate Cancer Prostatic Dis. 10: 288–292.PubMedCrossRefGoogle Scholar
  81. Yoshimura K, Sumiyoshi Y, Hashimura T, Ueda T, Kamiryo Y, Yamamoto A, Arai Y. (2003). Int J Urol. 10: 190–195.PubMedCrossRefGoogle Scholar
  82. Zelefsky MJ, Fuks Z, Hunt M, Lee HJ, Lombardi D, Ling CC, Reuter VE, Venkatraman ES, Leibel SA. (2001). J Urol. 166: 876–881.PubMedCrossRefGoogle Scholar
  83. Zelefsky MJ, Fuks Z, Hunt M, Yamada Y, Marion C, Ling CC, Amols H, Venkatraman ES, Leibel SA. (2002). Int J Radiat Oncol Biol Phys. 53: 1111–1116.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media LLC 2010

Authors and Affiliations

  • S. Namiki
    • 1
  • L. Kwan
    • 2
  • Y. Arai
    • 2
  1. 1.Department of UrologyTohoku University Graduate School of MedicineSendaiJapan
  2. 2.David Geffen School of Medicine(SN, YA)Jonsson Comprehensive Cancer Center University of CaliforniaLos Angeles (LK)USA

Personalised recommendations